Brinker Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-17,454
Closed -$307K 1007
2017
Q3
$307K Sell
17,454
-4,934
-22% -$86.8K 0.01% 805
2017
Q2
$744K Sell
22,388
-352
-2% -$11.7K 0.03% 444
2017
Q1
$730K Sell
22,740
-11,947
-34% -$384K 0.03% 481
2016
Q4
$1.26M Buy
34,687
+26,296
+313% +$953K 0.07% 252
2016
Q3
$386K Buy
8,391
+1,882
+29% +$86.6K 0.04% 233
2016
Q2
$327K Buy
6,509
+1,652
+34% +$83K 0.03% 220
2016
Q1
$259K Buy
+4,857
New +$259K 0.02% 229